News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Antibe Therapeutics Inc. Announces Non-Brokered Private Placement Of $3,000,000



3/24/2014 8:41:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV: ATE) announces its intention to complete a non-brokered private placement of 5,000,000 Common Shares of the Corporation at a price of $0.60 per Common Share for gross proceeds of $3,000,000 (the "Offering"). The Offering is expected to close on or about March 28, 2014, subject to TSXV approval, and to the satisfaction of customary closing conditions.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES